Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

US STOCKS-Wall Street gains on vaccine news, retail sales surprise

Published 10/17/2020, 02:13 AM
Updated 10/17/2020, 02:20 AM
US500
-
DJI
-
JBHT
-
IXIC
-
DJT
-
SPNY
-
PTON
-
BNTX
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window)
* U.S. retail sales accelerate in September
* Dow Jones Transport index drops
* Peloton falls on clip-in pedals recall
* Indexes up: Dow 0.87%, S&P 0.55%, Nasdaq 0.35%

(Updates to late afternoon, changes dateline, byline)
By Stephen Culp
NEW YORK, Oct 16 (Reuters) - U.S. stocks advanced on Friday
as further clarity regarding the timeline for the development of
a coronavirus vaccine and upbeat retail sales data and brought
buyers back to the market.
All three indexes were on track to snap a three-day losing
streak driven by halted vaccine trials and protracted pandemic
relief talks in Washington.
Still, they all looked set to post gains on the week.
Pfizer Inc PFE.N announced it could apply for U.S.
authorization for the COVID-19 vaccine it is developing with
German partner BioNTech 22UAy.F in November. Pfizer's stock
gained 3.4%. Retail sales USRSL=ECI in September blew past analyst
expectations and consumer sentiment for the current month
surprised to the upside, according to two separate economic
reports. But with previous stimulus having run its course, the
outlook is uncertain unless Washington can reach an agreement on
a fresh round of fiscal aid. "This was a strong showing by the consumer," said Peter
Cardillo, chief market economist at Spartan Capital Securities
in New York. "Even though we still have high unemployment, the
consumer hasn't changed his spending habits yet."
On that front, U.S. Treasury Secretary Steven Mnuchin told
House Speaker Nancy Pelosi that President Donald Trump would
"weigh in" with Senate Majority Leader Mitch McConnell if an
agreement is reached on a new pandemic relief package. House
Republican leader Kevin McCarthy, however, said he does not
expect an agreement to be reached ahead of the Nov. 3 election
as long as Pelosi is involved. "Investors are still very much concerned about the
uncertainties around the stimulus talks," said Cardillo. "We
could see something before the election but whoever wins the
election will probably give us a bigger stimulus package which
is desperately needed."
The Dow Jones Industrial Average .DJI rose 247.49 points,
or 0.87%, to 28,741.69, the S&P 500 .SPX gained 19.21 points,
or 0.55%, to 3,502.55 and the Nasdaq Composite .IXIC added
41.18 points, or 0.35%, to 11,755.05.
Of the 11 major sectors in the S&P 500, all but energy
.SPNY were in the black.
Third-quarter reporting season burst from the starting gate
this week, with 49 of the companies in the S&P 500 having
reported. Of those, 86% have cleared the low bar set by
expectations, according to Refinitiv.
Analysts now see S&P 500 earnings for the July to September
period dropping, in aggregate, by 18.7% year-on-year, an
improvement from the 21.4% plunge estimated at the beginning of
the month, per Refinitiv.
Oil services company Schlumberger NV SLB.N posted its
third straight quarterly loss due to falling crude prices and
plunging demand. Its shares dropped 7.8%. Railroad operator Kansas City Southern KSU.N shed 2.3% and
transportation and logistics company J.B. Hunt Transport
Services Inc JBHT.O tumbled 9.0% after the companies'
quarterly results were hit dropping shipping demand.
The Dow Jones Transport index .DJT , considered a barometer
of economic health, fell 0.8%. Shares of fitness company Peloton Interactive Inc PTON.O
were down 3.6% after announcing a recall of faulty pedals on its
popular exercise bikes.
Advancing issues outnumbered declining ones on the NYSE by a
1.22-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favored advancers.
The S&P 500 posted 50 new 52-week highs and no new lows; the
Nasdaq Composite recorded 91 new highs and 15 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.